3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
2
Breast Neoplasms
2
Wounds and Injuries
1
Stroke
1
Stomach Neoplasms
1
Spinal Cord Injuries
1
Rectal Neoplasms
1
Pain, Postoperative
1
Muscular Atrophy
1
Muscle Spasticity
1
Low Anterior Resection Syndrome
1
Hereditary leiomyomatosis and renal cell cancer
1
Ganglion Cysts
1
Esophageal Neoplasms
1
Cluster Headache
1
Carcinoma, Renal Cell
1
Breast Diseases
1
Brain Injuries
1
Interventions
ostarine
3
rimabotulinumtoxinB
1
Standard of Care
1
Olanzapine
1
Enteral Nutrition
1
Cyproheptadine
1
Creatine
1
Botulinum Toxins, Type A
1
Acetylcysteine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Muscular Atrophy
×
Botulinum Toxins, Type A
×
Clear all
NCT02052024
2015-12-16
MAS
Georgetown University
Phase 4
Completed
10 enrolled